• ABOUT US
    • COMPANY
    • TEAM
  • BUSINESS DEVELOPMENT
    • OVERVIEW
    • SERVICES & DEAL TYPES
    • PROCESS
    • TRACK RECORD
    • TEAM
  • MARKET ACCESS
    • OVERVIEW
    • SERVICES
    • PROCESS
    • TRACK RECORD
    • TEAM
  • PARTNERS
  • NEWS | EVENTS
    • MEETINGS
    • NEWS
    • PUBLICATIONS
  • CONTACT
Menü
  • ABOUT US
    • COMPANY
    • TEAM
  • BUSINESS DEVELOPMENT
    • OVERVIEW
    • SERVICES & DEAL TYPES
    • PROCESS
    • TRACK RECORD
    • TEAM
  • MARKET ACCESS
    • OVERVIEW
    • SERVICES
    • PROCESS
    • TRACK RECORD
    • TEAM
  • PARTNERS
  • NEWS | EVENTS
    • MEETINGS
    • NEWS
    • PUBLICATIONS
  • CONTACT

BUSINESS DEVELOPMENT

PROCESS

The business development process is based on three pillars: strategy, evaluation and execution.

Adherence to pre-defined, agreed timelines and milestones as well as proper management of the appropriate sequence of activities are key success factors.

We are managing your business development process in a customized and efficient way by analyzing the USPs and risk-benefit profile of your project, by carefully positioning the asset and selecting the deal type of choice, thus matching your project with the target profile of your target partner.

This allows us to address your potential partners in a tailored way. We provide hands on management in a well-planned, structured and goal-orientated process, involve specialist expertise as necessary and work in close collaboration with our clients throughout the process.

BUSINESS DEVELOPMENT PROCESS

SERVICES & DEAL TYPES

TRACK RECORD

TEAM

PUBLICATIONS

UPCOMING EVENTS

Online-Seminar, Forum
Dossierbewertung bei Lizensierung, Zulassungs-und Produktkauf

15. May 2025

PLCD Frühjahrstagung, Heidelberg

15. - 16. May 2025

OUR DEALS IN THE NEWS

Kebomed Europe secures license to distribute Womed Leaf®

April 9th, 2025

Womed licensed Womed Leaf® to Saesco Medical

April 9th, 2025

Transaction Advisor to Allecra Therapeutics GmbH

June 24, 2024

Transaction Advisor to Lallemand Pharma

March 20, 2024

Transaction Advisor to Retinagix Holdings, LLC

January 19, 2022

Transaction Advisor to Allecra Therapeutics GmbH

January 13, 2022

Transaction Advisor to GamaMabs Pharma SA

May 04, 2021

Transaction Advisor to Allecra Therapeutics GmbH

December 21, 2020

Transaction Advisor to German Cancer Research Center (DKFZ)

September 14, 2020

Transaction Advisor to Sapiotec GmbH

January 20, 2020

© 2025 Staatz Business Development | Imprint | Disclaimer